Recent Updates
Recently added Catalysts
Money and ownership

Short Interest and Days to Cover: How to Read a Crowded Short

BiopharmaWatch Research · Updated · 5 min read · Sources: FDA, SEC filings, ClinicalTrials.gov and our own price data
Short answer

Short interest is the number of shares that investors have sold short, betting the price will fall. Days to cover divides that number by the stock's average daily trading volume, so it tells you how many days of normal trading it would take for short sellers to buy their shares back. A high number means a crowded short.

What short interest and days to cover mean

A short seller borrows shares, sells them, and hopes to buy them back cheaper later. Short interest counts how many shares are sold short at a given time. Brokers report it twice a month, and the numbers become public about a week or two later.

Days to cover puts that number in context. If 10 million shares are short and the stock trades 1 million shares a day, days to cover is 10. Under 2 is low. Above 5 is crowded. Above 10 means short sellers would need two weeks of normal trading to get out.

Why a crowded short can push a stock up

When good news hits a stock with high days to cover, short sellers rush to buy shares back to limit their losses. That buying adds fuel to the move. People call it a short squeeze.

Erasca in September 2025 had days to cover above 14, and above 10 all summer. Thirteen hedge funds held the stock. It was at $2.18 at the end of September and $16.60 by April 2026, about 7.6 times higher.

The other side: short sellers are sometimes right

High short interest is not a buy signal on its own. Short sellers often know something. aTyr Pharma had days to cover above 10 in May 2025, with just one fund holding. In September its Phase 3 missed, and the stock fell from $6.03 to about $1 in a day.

Our data tells the same story. Across 22,234 past stock-months, biotechs with days to cover of 5 or more but only 0 to 2 funds holding rose 50% or more in six months 11.5% of the time, slightly worse than the 13.3% for all biotechs. With at least 5 funds holding, in 2025 and 2026 they rose that much 34% of the time, against 19% for all biotechs. In 2024 they did no better than average, and more than one in three fell 30% or more.

How to read short interest in three steps

  1. Look at days to cover, not just the share count.
  2. Check the trend over the last few months. Rising short interest into a catalyst tells you the bears are leaning in.
  3. Check who owns the stock. A crowded short against a stock that specialist funds also hold is a tug of war. A crowded short with nobody on the other side is often just a bad company.

See it live: Screen biotechs by days to cover, then read the short interest history on each company page.

Open the Company Screener →

Watch the video walkthrough

Prefer YouTube? Watch it there.

Frequently asked questions

Under 2 is low, 2 to 5 is moderate, 5 to 10 is high, and above 10 is very high. Above 10 means short sellers would need two weeks or more of normal trading volume to buy back their shares.

It is the total number of shares sold short and not yet bought back. It is often shown as a percentage of the shares that trade freely (the float).

Twice a month. Positions are counted in the middle and at the end of each month, and the numbers are usually published about a week or two later.

It can be either. It shows many investors expect the price to fall, which may be right. But if good news arrives, short sellers buying back can push the price up faster. Ownership and cash help tell the difference.

A short squeeze happens when a heavily shorted stock rises sharply, often on trial or FDA news, and short sellers rush to buy shares back, pushing the price even higher.

Educational content only. Not financial advice. Past results don't predict future ones.